AngioDynamics击败了Q1的预期收入,但面临2025财政年度的损失,股票出售。 AngioDynamics beat Q1 earnings expectations but faces FY 2025 losses, stock sells off.

AngioDynamics公司报告,1 2022年Q收入为每股0.3美元,超过预期,产生7 200万美元收入,略高于预测。 AngioDynamics reported Q1 2022 earnings of $0.03 per share, exceeding expectations and generating $72 million in revenue, slightly above forecasts. 尽管有这些积极的数字,收入却逐年下跌4.3%。 Despite these positive figures, revenue dropped 4.3% year-over-year. 该公司更新了2025财政年度指南,使EPS范围为-0.340至-0.310。 The company updated its FY 2025 guidance to an EPS range of -0.340 to -0.310. SVP Warren Nighan Jr.最近出售股票,股票以10.86美元开放,市场上限为4.3946亿美元。 SVP Warren Nighan Jr. recently sold shares, and the stock opened at $10.86 with a market cap of $439.46 million. AngioDynamic设计治疗血管疾病和癌症的医疗装置。 AngioDynamics designs medical devices for treating vascular diseases and cancer.